Virtual Institute MetBioMat: in vivo studies of biodegradable magnesium based implant materials

The Virtual Institute MetBioMat ended with a term of five years July 31, 2017.

In collaboration with the university hospitals of Hamburg, Hannover and Graz as well as further partners, the Helmholtz-Zentrum Geesthacht had established a Virtual Institute, whose focus was on degradable magnesium implants. One aim of the research association coordinated from Geesthacht was to develop first prototypes of orthopaedic implants.

The Virtual Institute MetBioMat was one of the Helmholtz Virtual Institutes and lead by Prof. Regine Willumeit-Römer of the Helmholtz-Zentrum Geesthacht. By establishing new research partnerships, Helmholtz Virtual Institutes provided a distinct benefit in preparing the way for larger strategic research projects. With this funding the Helmholtz Association wanted to strengthen the position of universities in the German scientific system. A further aim of the funding programme was to generate new collaboration with leading international partner institutions and the industry.

Helmholtz Virtual Institutes